Evangelos Terpos to Health Expenditures
This is a "connection" page, showing publications Evangelos Terpos has written about Health Expenditures.
Connection Strength
0.025
-
A cost-effectiveness analysis of denosumab for the prevention of skeletal-related events in patients with multiple myeloma in the United States of America. J Med Econ. 2018 May; 21(5):525-536.
Score: 0.025